Skip to main content

To learn more about Triangle CERSI, join our mailing list for future communications.

•

To learn more about Triangle CERSI, join our mailing list for future communications.

•

To learn more about Triangle CERSI, join our mailing list for future communications.

•

To learn more about Triangle CERSI, join our mailing list for future communications.

•

To learn more about Triangle CERSI, join our mailing list for future communications.

•

To learn more about Triangle CERSI, join our mailing list for future communications.

News

News

See what we’ve been up to and what’s ahead.

  • Featured

    The NAMolution of Regulatory Science Seminar Series

  • Featured

    Workshop: Advancing Novel Surrogate Endpoints For Rare Disease Drug Development

  • Featured

    Workshop: Pediatric Drug Development Safety and New Approach Methodologies (NAMs)

  • 0 for 4: Triangle CERSI Co-PI Debates the Use of IV Iron Supplementation in Patients with Heart Failure

  • Phantoms in Space: Triangle CERSI Co-PI Helps Test Deep-Space Radiation Protection

  • Triangle CERSI Co-PI Highlights New Prostate Cancer Risk Model at ASCO 2026

  • NAMeRS: An Accelerator Program to Support the FDA Roadmap to Reduce Animal Testing

  • Nabarun Dasgupta discusses street drug science at the May 2026 FDA CERSI Lecture Series

  • New Publication Advances More Meaningful, Patient-Focused Clinical Outcomes

  • Experts Debate the Role of Animal Testing at the 2026 CERSI Summit

  • Announcing NAMeRS: An Accelerator Program to Support the FDA Roadmap to Reducing Animal Testing

  • Index Date Selection for External Comparators - A Virtual Public Symposium for the Scientific Community

  • Paul Watkins interviewed by NBC News about CBD effects on the liver

  • July FDA CERSI Lecture Series features Duke Professor discussing pragmatic trials and real world data

  • UK CEiRSI announces formal partnership with Triangle CERSI

  • Virtual Imaging Trials in Medicine 2025

  • CERSI researcher Dasgupta interviewed on NPR's Morning Edition

  • CERSI PI Susan Halabi's clinical trial design leads to key finding for people with bladder cancer

  • Dr. Ehsan Samei interviewed by Radiological Society of North America

  • A Chat with Dr. Paul Watkins and Dean Kashuba of the UNC Eshelman School of Pharmacy

  • Episode 167 of Taking the Pulse: A Healthcare and Life Sciences Podcast

  • FDA gives $50M to Duke, UNC to establish world-class public health research center

  • UNC-Chapel Hill, Duke to be awarded up to $50 million from the FDA for new research center

FDA Regulatory Science News and Events

Visit the FDA CERSI website for news and events related to the Advancing Regulatory Science Initiative.